Bowie Capital Management LLC Buys 21,824 Shares of UnitedHealth Group Incorporated $UNH

Bowie Capital Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 265,051 shares of the healthcare conglomerate’s stock after buying an additional 21,824 shares during the period. UnitedHealth Group comprises about 4.0% of Bowie Capital Management LLC’s investment portfolio, making the stock its 16th largest holding. Bowie Capital Management LLC’s holdings in UnitedHealth Group were worth $91,522,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Korea Investment CORP increased its stake in shares of UnitedHealth Group by 2.4% during the third quarter. Korea Investment CORP now owns 658,229 shares of the healthcare conglomerate’s stock valued at $227,286,000 after buying an additional 15,298 shares during the period. Rhenman & Partners Asset Management AB grew its holdings in UnitedHealth Group by 105.5% during the 3rd quarter. Rhenman & Partners Asset Management AB now owns 62,530 shares of the healthcare conglomerate’s stock worth $21,592,000 after acquiring an additional 32,100 shares in the last quarter. Crabel Capital Management LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $267,000. Grantham Mayo Van Otterloo & Co. LLC boosted its stake in shares of UnitedHealth Group by 24.5% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 2,666,623 shares of the healthcare conglomerate’s stock valued at $920,785,000 after purchasing an additional 525,175 shares in the last quarter. Finally, Munich Reinsurance Co Stock Corp in Munich purchased a new position in UnitedHealth Group during the third quarter valued at approximately $60,268,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Morgan Stanley dropped their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research report on Friday, January 23rd. Leerink Partners dropped their price objective on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Truist Financial cut their price objective on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, February 2nd. Finally, Mizuho lowered their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $286.86 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. The firm’s 50 day simple moving average is $308.28 and its 200-day simple moving average is $325.83. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The stock has a market capitalization of $260.38 billion, a price-to-earnings ratio of 21.75, a PEG ratio of 1.32 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. The company had revenue of $113.73 billion for the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm’s revenue was up 12.3% on a year-over-year basis. During the same quarter last year, the business earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 3.1%. UnitedHealth Group’s dividend payout ratio is currently 67.02%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.